Sundar PichaiSundar Pichai earned $164M in 2023

Kendra Adams is the Chief Financial Officer and Treasurer at C4 Therapeutics, Inc., where she stepped into her role in September 2023. She has a solid background in finance, holding a Bachelor's degree in Economics from Hamilton College. Before joining...

Quick Links
C

Kendra Adams

CEO of C4 Therapeutics

Education

B.A. in economics from Hamilton College

Field of Expertise

Finance & Banking - Finance

Sector of Economy

Healthcare

CEO of C4 Therapeutics for

1 year 8 months (Sep 2023 - Present)

Previous Experience

Vice President, Investor Relations and External Communications at Agios Pharmaceuticals; investor relations roles at Ariad Pharmaceuticals and Amgen; finance roles at KPMG LLP and General Electric.

Rivals

Competitors/colleagues of Kendra Adams

Holdings

See how much did Kendra Adams make over time.

Kendra Adams has shown a strong commitment to C4 Therapeutics through her stock trading activities. In the past year, she has made several notable trades, showing considerable investment in the company. For example, her trading activity peaked in March 2024,...

Mar 18, 2025

Insider Trading

See recent insider trades of Kendra Adams.

CCCC

36,700 shares

CCCC

Feb 13, 2024

Received

CCCC

25,000 shares

CCCC

Sep 18, 2023

Received

Compensation History

See how much did Kendra Adams make over time.

In 2023, Kendra Adams' total compensation as the CFO of C4 Therapeutics was $550,000. Notably, this amount was solely her base salary, with no bonuses or stock options granted during the year. This reflects a straightforward approach to her compensation, focusing more on fixed income rather than performance-based incentives. This clear structure may indicate a desire to keep executive pay simple and tied directly to salary. While she is eligible for performance bonuses in future years, the absence of additional incentives in her compensation for 2023 highlights an emphasis on other strategic goals within the company. Kendra's financial background and leadership experience position her well to guide C4 Therapeutics through its next chapter, fostering growth and innovation in the healthcare sector.

Year

2023

Total Compensation

$550.00K

Salary

$550.00K

Board Justification

The compensation philosophy emphasizes aligning executive compensation with company performance and market competitiveness, focusing on attracting and retaining top talent.

Bonus

$0.00

Board Justification

No bonus was awarded for the year 2023.

Other

$0.00

Board Justification

No other compensation was reported for 2023.

Restricted Stock

$0.00(0 N/A)

Board Justification

No stock was vested in 2023 as the focus was on other compensation elements.

Performance Metrics

The performance metrics for Kendra Adams' compensation were not explicitly stated for 2023.

Other C4 Therapeutics CEOs

Here are other CEOs of C4 Therapeutics